Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Inspira Technologies Oxy BHN ( (IINN) ) has provided an update.
On July 7, 2025, Inspira Technologies announced it is in high-level talks with a government health authority outside the U.S. to integrate its ART100 system into national emergency infrastructure and establish a global distribution framework. The discussions, scheduled for July 8, 2025, aim to leverage the government’s international connections to enhance the profitability of a recent $22.5 million purchase order. This move marks a strategic shift from regional to global partnerships, potentially accelerating Inspira’s growth and industry influence.
The most recent analyst rating on (IINN) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on Inspira Technologies Oxy BHN stock, see the IINN Stock Forecast page.
Spark’s Take on IINN Stock
According to Spark, TipRanks’ AI Analyst, IINN is a Underperform.
The overall stock score reflects significant financial instability, as indicated by ongoing losses and reliance on external funding. The technical analysis shows bearish sentiment, with the stock under pressure. Valuation is challenging due to negative earnings and lack of dividend yield, making the stock less appealing to investors.
To see Spark’s full report on IINN stock, click here.
More about Inspira Technologies Oxy BHN
Inspira Technologies is a commercial-stage medical device company specializing in advanced respiratory support and real-time blood monitoring solutions. The company’s FDA-cleared INSPIRA ART100 system is approved for cardiopulmonary bypass in the U.S. and ECMO procedures outside the U.S. Inspira is also developing the INSPIRA ART500 and the HYLA blood sensor platform, positioning itself as a significant player in the life-support and MedTech industry.
Average Trading Volume: 779,899
Technical Sentiment Signal: Buy
Current Market Cap: $30.49M
See more data about IINN stock on TipRanks’ Stock Analysis page.